Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Alzheon Inc. (Framingham, Mass.) proposed to raise up to $80.5 million on March 16 in
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury